---
layout: page
title: >-
  IBD Stock Of The Day Synopsys Prospers As Chips Get More Complex
image: /assets/img/stock-of-the-day/2020-08-20.jpg
date: 2020-08-20 16:35 -0700
author: PATRICK SEITZ
---






**Synopsys** ([SNPS](https://research.investors.com/quote.aspx?symbol=SNPS)) is the [IBD Stock Of The Day](https://www.investors.com/category/research/ibd-stock-of-the-day/) after the chip design software firm crushed estimates with its fiscal third-quarter results. Synopsys stock surged into a [buy zone](https://www.investors.com/how-to-invest/investors-corner/buy-zone-nvidia-stock/) on the news Thursday.




On the [stock market today](https://www.investors.com/market-trend/stock-market-today/stock-market-today-market-trends-best-stocks-buy-watch/), Synopsys stock surged 8.6 to close at 215.16. Earlier in the session, it broke out of a six-week [flat base](https://www.investors.com/how-to-invest/investors-corner/chart-patterns-flat-base-dull-trade-positive-action/) at a [buy point](https://www.investors.com/how-to-invest/investors-corner/chart-reading-basics-how-a-buy-point-marks-a-time-of-opportunity/) of 205, according to [IBD MarketSmith charts](https://www.investors.com/product/marketsmith/?artProdLink=MarketSmith).


Late Wednesday, the Mountain View, Calif.-based company beat Wall Street's targets for its [fiscal third quarter](https://www.investors.com/news/technology/synopsys-earnings-q3-2020-snps-stock/) ended July 31. Synopsys earned an adjusted $1.74 a share, up 47% year over year, on sales of $964.1 million, up 13%. Analysts had predicted Synopsys earnings of $1.34 a share on sales of $894.1 million.


On a conference call with analysts, Co-Chief Executive Aart de Geus said demand for Synopsys products and services is strong. Synopsys is a leader in electronic design automation and semiconductor intellectual property. It also has a growing business in software security and quality solutions.





IBD Newsletters
---------------


#### Get exclusive IBD analysis and actionable news daily.




SIGN UP NOW!





IBD Newsletters
---------------


#### Get exclusive IBD analysis and actionable news daily.




* Financial Advisor Update
* How To Invest
* Market Prep
* Tech Report



Please enter a valid email address
Please select a newsletter


GO
Get these newsletters delivered to your inbox & more info about our products & services. [Privacy Policy](https://www.investors.com/investors-business-daily-privacy-policy/) & [Terms of Use](https://www.investors.com/home/investors-business-daily-inc-terms-of-use/)



x



Thank You!
----------


#### You will now receive IBD Newsletters




ALL DONE!




Something Went Wrong!
---------------------


#### Please contact customer service




CLOSE




Global Chip Design Activity Flourishing
---------------------------------------


"Even as the world navigates through the pandemic, a slowing economy, and geopolitical uncertainty, the market in which we operate remains robust," de Geus said. "Global design activity and customer engagements are flourishing, driven by unrelenting complexity of chip and system design."


Synopsys is benefiting from such growing segments as artificial intelligence, 5G wireless and cloud computing, he said.



Synopsys Stock Nabs Price-Target Hikes
--------------------------------------


On Thursday, Synopsys stock received a number of price-target hikes from Wall Street analysts.


RBC Capital Markets analyst Mitch Steves reiterated his outperform rating on Synopsys stock and upped his price target to 228 from 210.


"Notably, the company increased cash-flow expectations for the full year, which is an important metric for the growing number of software investors that follow the stock closely," Steves said in a note to clients.


KeyBanc Capital Markets analyst Jason Celino maintained his overweight rating on Synopsys stock and raised his price target to 225 from 200.


"We believe SNPS is executing well and remains a core idea to own," he said in a report.


Synopsys Ranks Fourth Among Design Software Stocks
--------------------------------------------------


Synopsys stock has an [IBD Relative Strength Rating](https://www.investors.com/how-to-invest/investors-corner/relative-strength-rating-stock-chart-analysis-helps-pick-outstanding-growth-stocks/) of 86 out of 99, according to the [IBD Stock Checkup tool](https://research.investors.com/stock-checkup/nasdaq-synopsys-inc-snps.aspx). That means it has outperformed 86% of stocks over the past 12 months. The best growth stocks typically have an RS Rating of at least 80.


Synopsys stock has an [IBD Composite Rating](https://www.investors.com/how-to-invest/investors-corner/how-to-research-growth-stocks/) of 89 out of 99.Â IBD's Composite Rating combines five separate proprietary ratings into one easy-to-use rating. The best growth stocks have a Composite Rating of 90 or better.


Synopsys ranks fourth out of 11 stocks in IBD's Computer Software-Design industry group. **Cadence Design Systems** ([CDNS](https://research.investors.com/quote.aspx?symbol=CDNS)) leads the group with an IBD Composite Rating of 98. **PTC** ([PTC](https://research.investors.com/quote.aspx?symbol=PTC)) is in second place, followed by **Ansys** ([ANSS](https://research.investors.com/quote.aspx?symbol=ANSS)).


The design software stock group ranks No. 45 out of 197 industry groups tracked by IBD.


*Follow Patrick Seitz on Twitter at [@IBD\_PSeitz](https://twitter.com/IBD_PSeitz) for more stories on consumer technology, software and semiconductor stocks.*


**YOU MAY ALSO LIKE:**


[Graphics-Chip Maker Nvidia Tops Views On Strong Data Center, Gaming Sales](https://www.investors.com/news/technology/nvidia-earnings-q2-2021-nvda-stock/)


[Chipmaker Analog Devices Beats Quarterly Targets, Guides Higher](https://www.investors.com/news/technology/analog-devices-earnings-q3-2020-adi-stock/)


[Put In Your Vote For The Most Trusted Financial Companies: Vote Here](https://mtfp2.sawtoothsoftware.com/login.html)


[Best Growth Stocks To Buy And Watch: See Updates To IBD Stock Lists](https://www.investors.com/stock-lists/best-growth-stocks-buy-watch-ibd-stock-lists/)


[Join IBD Live For Stock Ideas Each Morning Before The Open](https://shop.investors.com/offer/splashresponsive.aspx?id=IBD-Live&intcode=invstcntnartcls%7Ccms%7Cibdlive%7C2020%7C07%7Cibdlive%7Cna%7C%7C727112&src=A00433A)




